Atlas Trials

Personalized Immunotherapeutic for Antibiotic-resistant Infection

Clinical trial NCT02508584 · COMPLETED

Trial details

NCT number
NCT02508584
Sponsor
Brigham and Women's Hospital
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
InfectionImmune DeficiencyHypogammaglobulinemiaSeptic ArthritisMycoplasma Hominis
Start date
2016-04-12
Primary completion
2019-06-12
Enrollment
1

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.